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Human  T  cell  clones  and  monoclonal  antibodies  directed  at  their  surface 
glycoproteins have provided  a  considerable  amount of information about the 
nature of recognition structures on alloreactive, viral.specific and soluble antigen- 
specific human T  lymphocytes (1-6).  In each case, the antigen receptor of these 
cells  has  been  shown  to  be  a  T3-Ti  molecular  complex  that  consists  of one 
clonally unique  90-kD  Ti  molecule in noncovalent association with the mono- 
morphic 20/25-kD  T3  molecule (7-10).  While autoreactive T  cells have been 
defined in both human and murine systems as well, their recognition elements, 
in contrast to cells with the above specificities, have not been identified (11-18). 
However,  target  molecules from these  latter cells could be either the antigen 
receptors  on  other  effector  populations  or  alternatively,  autologous  surface 
components including MHC gene products. 
To  investigate  autoreactive  cells  at  the  clonal  level,  we  utilized  a  major 
histocompatibility  (MHC) ~  restricted/antigen-specific  inducer  clone,  termed 
RW 17C in the present study, as a stimulus for proliferation, cloned the respond- 
ing T  cells and then studied their specificity and function. The results,  to be 
reported below, indicate that the majority of such clones are derived from the 
T4+  subset and are  reactive with autologous MHC  class  II  molecules.  These 
"autoreactive" cells provide  inducer as well as amplifier function for B  cell  Ig 
production in the absence of exogenous antigen since only self-MHC recognition 
is required  for activation.  Functional and biochemical analysis of such  clones 
demonstrates that, similar to conventional "antigen-specific" clones, they use a 
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comparable T  cell receptor comprised of a T3-Ti molecular complex for recog- 
nition of autoiogous MHC. 
Materials and Methods 
Isolation of Lymphoid Populations.  Macrophages were obtained from mononuclear pop- 
ulations by standard adherence techniques. Subsequently, macrophage-depleted mono- 
nuclear cells  were  separated  into  erythrocyte (E)  rosette positive (E+)  and  E  rosette 
negative (E-) populations with 5% sheep E (Microbiological Associates,  Bethesda, MD). 
The rosetted mixture was layered over Ficoll-Hypaque and the recovered E+ pellet was 
treated with 0.155 M  NH4CI  to lyse erythrocytes. The T  cell population obtained was 
>95% E+ and >90% reactive with monoclonal antibody anti-T3, which defines an antigen 
present on all  mature peripheral T  lymphocytes (19).  The E- population was further 
fractionated into B cell populations by complement-mediated lysis with anti-T3 and anti- 
Mol (20). Reanalysis of antibody and complement lysis of E- cells demonstrated that the 
B cell population was >94% reactive with anti-B1 (21). 
Generation and Culture of Human T Cell Clones.  The human T  cell clone RW17C was 
derived by stimulating peripheral blood lymphocytes of a healthy donor with ragweed 
antigen E (RWAGE) (Worthington Diagnostic Systems, Freehold, NJ) followed by cloning 
as previously described (22).  Briefly, peripheral blood mononuclear cells (PBMC) were 
incubated with RWAGE (Worthington Diagnostics) for 6 d and then cloned in a semi- 
solid agar system. Individual colonies were expanded in liquid culture by restimulation 
with RWAGE, 5,000 rad irradiated autologous PBMC, and interleukin 2 (IL-2)-contain- 
ing supernatants for >8 mo. Further cloning was performed by limiting dilution technique 
at  one  cell/well.  The  surface  phenotype  of  RW17C  was  TI+T3+T4+T8-Tll+ 
T12+Ia+, as analyzed by indirect immunofluorescence on an Epics V cell sorter (Coulter 
Electronics, Hialeah, FL). 
The autoreactive human T  cell clones (AC) were derived by stimulating lymphocytes 
of the same donor as  RW17C  with autologous T  cell clone RW17C  and cloning and 
recloning  responding  cells  (22).  To  this  end,  PMBC  were  stimulated  with  an  equal 
concentration of irradiated RW17C  for 5 d  in final culture medium  RPMI  1640 with 
10%  human  AB serum.  Cloning of activated cells  was  performed in a  two-layer soft 
agar  system.  After  6-9  d,  agar  colonies  were  individually  transferred  into  round- 
bottom  microtiter  plates  (Costar,  Cambridge,  MA)  containing  0.1  ml  of irradiated 
feeder cell  suspension (0.75  x  106 autologous whole mononuclear cells and 0.5  x  10  ~ 
RW17C  per ml).  At this  time,  the  culture medium  was  supplemented with  5%  IL-2. 
Subsequently,  the  cultures  were  expanded  by feeding every 2-3  d  with  IL-2-condi- 
tioned medium and weekly restimulation with irradiated feeder cells. Recloning was per- 
formed by limiting dilution in terasaki plates at 0.3 cells per well in the presence of 5% 
IL-2  and  irradiated  feeder  cells.  Several  subclones  were  expanded  and  maintained 
in  culture  for 6  months.  The  surface phenotype of individual  AC  clones  was  either 
TI+T3+T4+T8-T1 I+T12+TQI-Ia+ or TI+T3+T4-T8+TI  I+T12+TQI-Ia+. 
IL-2.  IL-2-containing supernatants were produced by stimulating whole peripheral 
mononuclear cells with phytohemagglutinin and phorbol myristate acetate in the presence 
o'f inactivated B cell line Laz 156, as described (17). 
Generation of Monoclonal Antibodies and Heteroantisera.  The following monoclonal anti- 
bodies were utilized in the present study and purified as previously described (6). Anti- 
T1 (reactive with the total T  cell population); anti-T3 (all mature T  lymphocytes and a 
fraction of thymocytes); anti-T4 (human inducer population); anti-T8 (human suppressor 
population); anti-T11  (E+ human lymphocyte); anti-T12 (all mature T  cells); anti-TQ1 
(reactive with 70-85% of T4+ inducer cells) (18). Anti-p29,34 is a turkey heteroantisera 
against human Ia antigen (monomorphic region of MHC class II gene product) and was 
provided by E. Yunis (Dana-Farber Cancer Institute) and prepared as described (24). w6/ 
32 anti-HLA monoclonal antibody was purchased from Sera laboratories (Sussex, England) 
(20). Anti-Ia framework (monomorphic, 9-49) was kindly provided by Dr. Robert Todd 
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Phenotypic Analysis ofT Cell Surface Antigens.  Phenotypic analysis of T  lymphocytes was 
performed by means of indirect immunofluorescence with a panel of monoclonal antibod- 
ies and goat anti-mouse F(ab')~ fluorescein isothiocyanate (FITC) on an Epics V cell sorter 
(Coulter Electronics). For quantification by flow cytometry, the cells were incubated with 
saturating concentrations of monoclonal antibody and goat anti-mouse FITC. Quantifi- 
cation by this method is possible since fluorescence measured by a fluorescence-activated 
cell sorter is proportional to the number of bound fluorescein molecules per cell and in 
linear with the channel number using a  linear amplifier (26).  The present quantitations 
are based on a valid calibration curve linear and logarithmic fluorescence on the Epics V 
cell sorter (27). Since homogeneous fluorescence peaks were essentially gaussian on the 
log scale, their average fluorescence intensities were determined as the geometric mean 
(that  is,  the  arithmetic  mean  channel  number  of log amplified intensities).  Each  cell 
population was analyzed several times with consistent results (variations <10%). 
Modulation  of Surface Antigens by Monoclonal Anti-T3 Antibodies.  AC3 cells at 1 ×  106/ml 
were incubated with  saturating amounts of anti-T3  antibody for  18  h  at  37 C  in final 
culture medium RPMI  1640 plus  10%  human AB serum.  Subsequently, the cells were 
washed three times and analyzed for expression of T3 by means of indirect immunofluo- 
rescence on the FACS before assessment of their functional properties. 
Radiotabeling and Immunoprecipitation  ofT Cell Surface Antigens.  Cell surface iodination 
of T  cell clones was performed with  Na  ~25I (New England  Nuclear,  Boston, MA) and 
catalyzed by lactoperoxidase.  To  20  ×  106  cells  suspended  in  1  ml  PBS  were  added 
successively 10 #1 glucose (0.5 tool/liter), 5 ttl NaI (5 ×  104 mol/liter), 10 ~1 lactoperoxidase 
(2  mg/ml),  1 mCi  Na  l~sI, and  20 #1  glucose oxidase (7.5  mU/ml). This mixture was 
incubated for 15 rain at room temperature followed by addition of 100 t~l NaI (1 mol/1). 
After an additional 2 min of incubation, cells were washed four times in Hank's balanced 
salt solution. The final pellet was lysed in 500 #1  1:5 diluted radioimmune precipitation 
assay (RIPA) stock solution containing 1% Triton X-100 (RIPA stock solution: 0.1  mol/1 
NaH~PO4, 1 mmol/l phenylmethylsulfonyl fluoride, 10 mmol/l EDTA, 10 mmol/l EGTA, 
10  mmol  NaF,  1%  deoxycholate  sodium  salt,  200  KIU/ml aprotinin,  pH  7.2).  The 
suspension  was  centrifuged  for  5  min  at  1,120  g  and  the  resulting  supernatant  was 
precleared twice using monoclonal antibody anti-T6 covalently linked to CnBr-activated 
Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden), each for 60 min at 4°C and 
subsequently  centrifuged  5  min  at  1,120  g.  Precleared  lysates  were  incubated  with 
monoclonal  antibodies  bound  to  CnBr-activated  Sepharose  4B  for  2  h  at  4°C.  The 
resulting precipitate was  subsequently washed five times in  RIPA solution  (stock  1  :I0 
diluted) plus  1% Triton X-100 resuspended in gel buffer (0.125 tool/liter Tris-HCl, pH 
6.8, containing 10% glycerol, 3% sodium dodecyl sulfate [SDS] in the presence or absence 
of 5% 2-mercaptoethanol) and boiled for 5 min. SDS polyacrylamide gel electrophoresis 
(PAGE) was performed on a continuous vertical slab gel (10% polyacrylamide) for 14 h 
according to a modification of the Laemmli procedure (28). 
Proliferative Studies.  The T  cell clones and irradiated stimulator cells were plated into 
round-bottomed microtiter plates in  a  total volume of 200  #1 of supplemented  RPMI 
1640 containing 10% human AB serum when IL-2-conditioned medium was used (final 
concentration,  5-10%).  After a  24-h or  72-h  incubation at  37°C,  the  various cultures 
were pulsed with  1 #Ci of tritiated thymidine (3H-TdR) (Schwarz/Mann,  Div. of Becton 
Dickinson,  Orangeburg,  NY) and harvested  18  h  later on a  MASH II apparatus (M.S. 
Bioproducts, Walkersville, MD). 3H-TdR incorporation was then measured in a scintilla- 
tion counter (Packard Instruments, Downers Grove, IL). Each value represents the mean 
of triplicates +  standard deviation (SD). 
bz Vitro Analysis of Regulatory Functions on IgG Production.  AC3 or RW17C cells (30 × 
103) were cultured with B lymphocytes (5 ×  104) with or without RWAGE (final concen- 
trations 5 #g/ml) in a  total volume of 0.20 ml in 96-well U-shaped tissue culture plates 
(Flow Laboratories, McLean, VA) in RPMI 1640 (Gibco Laboratories, Grand Island, NY) 
containing  10%  FCS (M.A. Bioproducts). After 7 d  incubation at 37°C in a humidified 
atmosphere  containing  6%  CO2,  the  wells  were  harvested  by  pooling  the  cells  and 
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amounts of IgG secreted varied considerably among individual experiments (e.g. maximal 
IgG concentration between 1 and 15 t~g/ml). Nevertheless, in all experiments RW 17C or 
AC3, respectively, induced a 25-30-fold IgG secretion as compared with the autologous 
B cell and RWAGE. 
RIAfor lgG.  A solid phase RIA for IgG was performed in disposable flexible polyvinyl 
microtitration plates containing 96  U-bottomed wells  (Cat.  No.  1-220-24B,  Dynatech, 
Alexandria, VA).  Specifically, individual wells of the plates were coated with 100 #! of a 
1:20 dilution of the immunoglobulin fraction of rabbit anti-human IgG (chain specific) 
antiserum (Dakopatts A/S, Denmark) overnight at room temperature. The coating anti- 
bodies were aspirated and saved for re-use. The plates were washed three times with 
diluent of PBS containing 10% BSA for 1 h at room temperature. The plates were washed 
once and at this stage could be stored at 4°C in PBS 1% BSA containing sodium azide. 
Multiple  point  standard  curves  were  prepared  using  doubling dilutions  of normal 
human serum (NHS). The IgG content of NHS was standardized against the Australian 
standard reference serum for i  mmunoglobulin (ASPS 78/1). Aliquots (100 #l) of standard 
or culture fluids were added to individual wells in triplicate and allowed to stand overnight 
at room temperature. The plates were then washed three times with diluent and  100 #1 
containing 5 ng of ~25I-labeled IgG solid phase adsorbed rabbit anti-human IgG antiserum 
(Calbiochem-Behring Corp., La Joila, CA) was added to each well. The antibodies were 
labeled with sodium iodide (~5I) for protein iodination (Amersham International, Amer- 
sham,  UK)  using  Enzymobead Reagent  (Bio-Rad  Laboratories,  Richmond,  CA)  to  a 
specific activity of 4,000 cpm/ng. After 4-6 h incubation, the plates were washed I 0 times 
with PBS. The individual wells were cut apart and counted in an auto-gamma scintillation 
spectrometer (Packard). Standard curves in this RIA were linear between 1 and 250 ng 
IgG per ml. Whenever the concentration of IgG in a culture supernatant exceeded 250 
ng/ml, it was diluted so that it would fall in this range. 
Results 
Generation of Autoreactive Clones.  Evidence exists to support  the  notion  that 
autoreactive  T  cells  circulate  in  human  peripheral  blood  (11-15).  However, 
neither  the  precise  nature  of the  recognition  structures  on  the  responding 
population nor the target antigens that serve as their stimulus have been defined. 
To address  these  questions  at  the  clonal  level, a  series  of T  cell clones  were 
generated against an autologous, antigen-specific T4+  clone, termed  RW17C. 
For this purpose, peripheral blood mononuclear cells (PBMC) were sensitized in 
vitro to irradiated  RW17C  for 6  d  and cloned in a  two-layer soft agar system. 
The agar colonies were picked, expanded, and then recioned by limiting dilution 
as  previously described.  After  1  month  of in  vitro  expansion,  cultures  were 
screened  for  reactivity  with  anti-T4  and  anti-T8  monoclonal  antibodies  by 
indirect immunofluorescence on an  Epics V  cell sorter.  Of the initial  cultures 
screened,  20  AC  showed  a  homogeneous phenotype in  terms  of anti-T4  and 
anti-T8 reactivity. 13 of these expressed the T4 surface determinant, whereas 7 
expressed  the  T8  antigen.  The  former  (phenotype:  T3+T4+T8-Tll+Ia+) 
were maintained in in vitro continuous culture for >6 months and are the subject 
of the present report. 
Proliferative Responses of  Autoreactive Clones.  Because the resulting clones might, 
in  principle,  be  directed  either at  surface  structures  unique  for  RW17C  (i.e. 
RW 17C T  cell receptor) or autologous lymphoid structures present on other T 
and/or B  cells from the  same  individual,  the ability of individual  autoreactive 
clones  to  proliferate  to  RW17C  and  an  autologous  Epstein-Barr  virus  (EBV) 
lymphoblastoid  line  termed  Laz 509  were  tested.  The results  of proliferation BENSUSSAN  ET  AL.  563 
studies for seven representative clones is shown in Table I. Although our initial 
expectation was that AC1-7 might proliferate to RW 17C, they responded mini- 
mally despite the fact that the AC clones were stimulated in the bulk cultures 
with RW17C.  In contrast, all seven clones proliferated to the autologous EBV- 
transformed lymphoblastoid line Laz 509. Moreover, the specificity of these anti- 
clones for autologous cells was clear because they did not proliferate to allogeneic 
B lymphoblastoid lines (Laz 156). It is possible that IL-2 consumption by RW17C 
accounted for its apparent inability to stimulate ACI-13;  however, exogenous 
IL-2 activity could be detected in culture supernatants of irradiated RW 17C cells 
for 48 h (data not shown). 
Since it was previously shown that the majority of cytotoxic T4+ clones were 
directed at  unique determinants on class II molecules (1-3),  we examined the 
ability of monoclonal antibodies directed against class I and class II MHC gene 
products to block proliferation of the autoreactive clones. As shown in  Fig.  1, 
preincubation of the irradiated Laz 509 stimulator ceils with an anti-Ia monoclo- 
nal  antibody  to  an  invariant  region  of the  29/34  structure  (or  anti-p29,  34 
heteroantiserum) diminished the proliferation of a representative clone by ~50% 
(40,000 cpm vs. 90,000 cpm; lane 5 vs. 4). In contrast, the monoclonal anti-HLA 
antibody had no effect (lane 6).  Moreover, the inhibition  of proliferation me- 
diated  by  anti-Ia  antibody  was  specific  for  the  antigen-induced proliferative 
response  of  AC3  because  IL-2-mediated  proliferation  was  not  significantly 
diminished  (52,000  vs.  46,000  cpm;  |anes  7  and  8).  Similar  findings  were 
observed with all the other AC clones tested. That these AC clones proliferated 
to  autologous  B  lymphocytes in  xenogeneic serum  as  well  as  autologous  or 
allogeneic human serum, makes it unlikely that any serum component was being 
recognized in conjunction with self-class II molecules. Furthermore, since non- 
T  cells from several HLA-D region matched allogeneic individuals could not 
trigger the AC3 clone to proliferate, it is probable that the epitope of the class 
II molecule being recognized is of a private specificity and more restricted than 
that defined by serologic means (data not shown). 
Next the capacity of different autologous cell populations to trigger the AC 
TABLE  I 
Reactivity of AC Clones Against an Autologous EBV-Transformed Lymphoblastoid B Cell Line 
Medium 
Autologous EBV-  Allogeneic EBV- 
Specific autologous  transformed lyre-  transformed lym- 
T  cell clone  phoblastoid B cell  phoblastnid B cell 
(RW17C)  line (Laz 509)  line (Laz 156) 
ACI  60 +  22  123  -+ 106"  3,679 ±  256  213 ±  51 
AC2  62 ±  8  125 ±  98  3,166 ±  118  65 ±  10 
AC3  71  ±  33  50 ±  20  3,182 ±  120  189 +  68 
AC4  101  ±  46  134 ±  112  2,554 ±  102  134 ±  50 
AC5  47 ±  21  170 ±  78  3,858 ±  288  231  ±  10 
AC6  85 ±  30  56 ±  21  1,597 ±  108  87 ±  17 
AC7  45 ±  4  176 ±  78  2,460 ±  93  62 ±  2 
* SH-TdR mean ±  SD of triplicate samples. 
10 4 cells of each AC were cocultured with  15  ×  l0  s irradiated cells and subsequently SH-TdR 
incorporation was measured on day 2. Results are expressed as cpm ±  SD. 564  T4+  AUTOREACTIVE  CLONES 
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FIGURE  1.  Influence of anti-la and anti-HLA antibodies on proliferative responses of clone 
AC3.  3  x  104 cells of clone AC3  were cultured with either:  l,  medium; 2, anti-la; 3, anti- 
HLA; 4, irradiated Laz 509; 5, irradiated Laz 509 and anti-Ia; 6, irradiated Laz 509 and anti- 
HLA; 7,  10% IL-2 containing supernatants; 8,  10% IL-2 containing supernatants and anti-la; 
and 9,  10%  IL-2 containing supernatants and anti-HLA.  Final dilutions of the monoclonal 
antibodies were anti-Ia,  1:250 and anti-HLA,  1:50. SH-TdR incorporation was measured on 
day 2. Results are expressed as cpm +  SD and representative of four such experiments. 
clones was determined  and  compared  with  their  ability to activate  the  MHC/ 
antigen-specific clone RW 17C used in the original stimulation. In addition, given 
the apparent specificity of the T4+ ACI-13 clones for au:ologous Ia molecules, 
binding  sites  for  anti-Ia  were quantitated  on  each  stimulator  cell  by indirect 
immunofluorescence.  As shown in  Table  II, the representative autocione AC3 
proliferates  to  autologous  B  cells,  rnacrophages,  and  the  EBV-transformed  B 
lymphoblastoid line.  Moreover, whereas the response to resting T  cells, B cells, 
macrophages, and autologous B lymphoblastoid cells correlated with the number 
of Ia molecules which they express, little response was induced by activated T 
cells  including  RW17C and  four  other  T  cell  clones of differing  specificities 
which  were  either  T4+Ia+  or  T8+Ia+,  despite  the  fact  that  they  expressed 
20,000-40,000 la sites per cell (Table II, data not shown). Whether the inability 
of these T  cells to induce  significant  AC3  proliferation  was a  consequence of 
their low level of Ia expression or alternatively, secondary to absence of a critical 
Ia molecule that is required for secondary T  cell stimulation is not known at the 
present time. Similar findings were observed with AC1, 2, 5, and 6.  In no cases BENSUSSAN ET AL.  565 
TABLE  II 
Clone AC3 Is Activated by Autologous Cells 
Number of Ia 
Stimulus  molecules* 
Proliferation 
AC3  RW 17C 
Autologous T cells  <_-3,000  90 __ 1  350 4- 172 
Autologous T cell clone  40,000  820 4- 6  360 4- 152 
Autologous B cells  60,000  4,560 4- 600  113 4- 100 
Autologous B cells + RWAGE  4,832 4- 720  1,019 4- 204 
Autologous macrophages  ! 20,000  18,882 4- 1,012  430 4- 95 
Autologous macrophages +  18,954 4- 320  9,754 4- 1,009 
RWAGE 
Autologous EBV transformed B  >500,000  82,621 + 2,532  350 4- 172 
cell line (Laz 509) 
Medium  --  78 + 4  270 4-  150 
IL-2  --  54,510 4- 568  3,256 4- 269 
* Binding sites/stimulator cell. 
3 x 10" cells of AC3 or RW 17C were cocultured with 5 x 104 irradiated stimulator ceils. Ragweed 
antigen E (RWAGE) was utilized at a final concentration of 20 tLg/ml and IL-2 at 10% vol/vol. 
Proliferation was assessed by measuring incorporation of 3H-TdR on day 2. Number of Ia molecules 
was calculated as described in Materials and Methods. Results are expressed as cpm + SD. 
however, were the autoclones cytotoxic for T  cells, B cells, or macrophages (data 
not shown). 
Table II also shows that the representative AC3 autoclone was clearly distinct 
from RW 17C in that AC3 was triggered to proliferate by autologous MHC class 
II  expressing  B  cells  or  macrophages  alone,  whereas  RW17C  required  both 
autologous  B  cells  and/or  macrophages  and  the  exogenous  soluble  antigen 
(RWAGE).  Note that  the autologous macrophages presented RWAGE antigen 
better than autologous B cells to RW17C as judged by 3H-TdR (9,700 vs.  1,000 
cpm, respectively). Whether this difference relates to the greater expression of 
autologous class  II  molecules on  the  former is  not  known,  but appears  likely. 
Table  II  further demonstrates  that the relative magnitude  of the proliferative 
response to a given stimuli was greater for AC3 than RW17C in all cases. 
Immunoregulatorv  Function  of Autoreactive  Clones.  The  finding  that  AC3  and 
the other AC clones failed to proliferate to RW17C but rather proliferated to B 
cells and  macrophages,  suggested  that  they might,  in  turn,  affect other B  cell 
functions. To test the ability of AC3 to influence IgG synthesis by autologous B 
lymphocytes, this  clone and  the  MHC-restricted antigen-specific inducer clone 
RW 17C was examined in parallel. To this end, 5 ×  104 autologous or allogeneic 
B  lymphocytes were incubated for 7  d  at  37°C  with  3  x  104  AC3  or RW17C 
cells  in  the  presence  or  absence  of ragweed  antigen.  Subsequently,  culture 
supernatants  were harvested and analyzed for IgG in a  solid phase radioimmu- 
noassay as previously reported. As shown in Fig.  2, panel A, AC3  induced IgG 
secretion from autologous B cells (lanes a and b, >14,000 ng/ml) in the presence 
or absence  of exogenous  RWAGE  antigen.  In  contrast,  allogeneic  B  cells  or 
autologous or allogeneic macrophages  were incapable of inducing Ig secretion 
in the presence of AC3 (c-f, <500 ng/ml). In addition, lane g indicates that AC3 
could induce allogeneic B  lymphocytes to produce Ig in the presence of autolo- 
gous macrophages.  In  that  the  latter do not,  by themselves, produce  Ig when 566  T4+  AUTOREACTIVE CLONES 
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FIGURE 2.  Induction of IgG secretion from autologous B lymphocytes by clone AC3 and 
clone RW17C. 3 x  10  4 cloned T  cells (panel A =  AC3; panel B =  RW17C) were cocultured 
in 10% FCS with the various stimuli listed below. After 7 d of culture, the wells were harvested 
and IgG secretion measured by solid phase radioimmunoassay. Results of one of five repre- 
sentative experiments are shown and expressed as #g/ml of buman IgG. SD for triplicate 
samples was always _<5%. Stimuli were as follows: (a,j) autologous B cells; (b,k) autologous B 
cells and RWAGE (5 t~g/ml); (c,1) allogeneic B cells; (d,m) allogeneic B cells and RWAGE (5 
#g/ml); (e,n) autologous macrophages; (f,0) allogeneic macrophages; (g,p)  allogeneic B cells 
and autologous macrophages; (h,q) autologous B cells and allogeneic macrophages; (i,r) allo- 
geneic B cells, autologous macrophages and RWAGE. 
stimulated by AC3 (lane e), these results suggest that the autologous macrophages 
served  to  trigger  the  autoreactive  clone  that  subsequently  provides  inducer 
function to ailogeneic B cells in a  non-MHC restricted fashion.  Note that the 
removal of all peripheral blood T  cells from the non-T population with anti-T3 
and complement (see Materials and Methods) rules out the possibility that IL-2 
secretion by AC3 induced a normal "contaminating" T cell population to produce 
BCDF and facilitate B cell differentiation. 
In  contrast to  AC3,  RW17C  provided  inducer function for B  lymphocytes 
only in the presence of the soluble antigen RWAGE. Thus, as shown in panel B, 
RW17C plus autologous B lymphocytes yielded no Ig production (j),  whereas 
the same combination plus  RWAGE antigen provided >10,000  ng/ml (k). In 
contrast, allogeneic B lymphocytes with or without RWAGE antigen were not 
induced to secrete Ig (l and m). Note that as with AC3, allogeneic B lymphocytes 
could be induced by RW17C to produce Ig but in the latter case this required 
autologous macrophages and RWAGE (r). 
Because the specificities of RW17C and AC3 were distinct, it was of interest 
to determine whether the inductive effects of these two clones were also different. 
To investigate this question and explore the possibility of a synergistic effect of 
these two inducer populations, an increasing number of RW17C  or AC3 cells 
were added to autologous B cells individually or together and subsequently, total 
Ig measured after 7 d. As shown in Fig. 3, Ig production by the combination of 
B  +  RW17C  +  AC3  (_>3,500  ng/m])  was always greater than  B  +  RW17C 
(<1,000 ng/ml) or B +  AC3 (<1,000 ng/ml) alone or the sum of the latter two b 
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FIGURE 3.  Amplifier effect of clone AC3 on IgG secretion induced by RW 17C clone. 5 x 
10  4 autologous B cells and 5 #g/ml RWAGE were cultured with: increasing numbers of either 
AC3 cells (O  O), RW 17C cells (A  A), or a mixture of AC3 and RW 17C (O~-----@).  Note 
that the number of cloned T cells in this latter case represent the sum of AC3 and RW17C 
added in the assay. IgG secretion was measured on day 8 and the SD of each concentration 
was <5%. 
(<2,000 ng/ml). While the absolute amount of IgG ( 1  - 15 #g/ml) secreted during 
the  7-d culture  period  varied among each of six  individual  experiments,  in all 
cases RW 17C and AC3 each alone induced 25-30-fold increases in IgG secretion 
over  base  line  B  cell  production  with  RWAGE,  whereas  the  combination  of 
RW17C plus AC3 provided _>100-fold increase in IgG secretion. These findings 
provide  strong  evidence  to  support  the  notion  that  RW17C  and  AC3  clones 
function in a  synergistic manner either by inducing different B  cell populations 
to secrete Ig or alternatively, by inducing more Ig from the same B cell. 
Surface Molecules on Autoreactive  T  Cell Clones.  From studies with ailoreactive 
human  T  cell  clones,  it  has been  demonstrated  that  several  surface  molecules 
appear to be involved in antigen  recognition by human T  lymphocytes (8-10). 
These include  the  monomorphic  20/25-kD  T3  structure  that  is present  on  all 
mature T  lymphocytes and  the  subset-specific associative recognition  elements, 
T4 and  T8.  More recently,  Ti, a  clonally unique  receptor structure  comprised 
of a  49-51-kD  a  chain  and  a  43kD  13  chain,  linked  to  T3  was  identified  on 
several of these clones and shown to co-modulate with the T3 structure. 
To examine the  important T  cell surface structures  required  for recognition 568  T4+  AUTOREACTIVE CLONES 
of autologous  MHC  gene  products,  both  antibody  blocking  studies  and  T3 
modulation studies were performed. As shown in Table III, AC cells proliferate 
to  IL-2-containing  supernatant  as well  as  the  autologous  B  cell  line  Laz  509. 
Pretreatment of AC3 with purified anti-T3 or anti-T4 antibody markedly reduces 
antigen-specific  proliferation  of the  AC3  clone.  Thus,  whereas  the  untreated 
AC3  clone  proliferated  with  >80,000  counts  of  3H-TdR  to  Laz  509,  AC3 
preincubated  with anti-T3  or anti-T4  proliferated  with <13,000  cpm, a  >80% 
reduction of proliferation. That these effects were not simply due to inactivation 
or AC3 as a  result of antibody treatment is clear from the fact that (a) anti-T8 
(Table  III) and anti-HLA  (Fig.  1)  have no inhibitory effects in  this system and 
(b) the antibody treatment has no effect on subsequent IL-2 induced proliferation 
(Table III). 
The above proliferative studies were performed in the presence of the purified 
monoclonal antibodies. Since the T3 structure has been previously demonstrated 
to modulate  from the  cell surface during  incubation  with anti-T3  antibody for 
18 h  at 37°C,  it was possible to examine the proliferative responses of the AC3 
population in the absence of the T3 molecule and the  anti-T3  directed toward 
it.  As  shown  in  Table  IIIB,  AC3  no  longer  proliferates  to  Laz  509  (133  vs. 
>20,000 cpm) following anti-T3 modulation. In contrast, in the modulated state 
IL-2 responsiveness  is markedly enhanced  (>20,000  vs.  6,300  cpm), an  obser- 
vation noted noted previously for alloreactive CTL clones (9). 
Recent  studies  indicated  that  the  Ti  receptor  molecules  on  individual  T4+ 
and TS+  clones are contained within a  molecular complex with T3 and can be 
detected  in  SDS-PAGE  of anti-T3  immunoprecipitates  from  ~I-labeled  ailo- 
reactive clones  (29).  To determine  whether  an  analogous  clonotypic  structure 
was likewise found in the anti-T3 immunoprecipitate from AC3, immunoprecip- 
itation  experiments  were  performed  with  externally  labeled  ~25I membrane 
preparations  from AC3.  As shown  in  Fig.  4,  monoclonal anti-T3c  precipitates 
TABLE  III 
Influence of Monoclonal Anti-T Lymphocyte Antibodies on Proliferative Responses of Clone AC3 
Antibodies in culture 
A. 
Medium  Anti-T3  Anti-T4  Anti-T8 
Medium  76 ± 16  93 ± 19  68 ± 20  92 ± 12 
Laz 509  88,621 ± 2,557  11,477  ± 888  12,131 ± 894  95,915 ± 3,694 
IL-2  58,042 + 485  59,492 ± 1,138  47,756 ± 1,124  54,394 + 550 
Anti-T3 modulation 
B. 
Unmodulated  Modulated 
Medium  17 _ 3  21 ± 5 
Laz 509  20,569 --- 1,253  133 ± 10 
IL-2  6,339 ± 243  21,353 ± 1,018 
(A) 3 ×  10  ~ cells of AC3 were cultured  either in media, with 5 x  104 irradiated  autologous EBV 
transformed lymphoblastoid B cell line (Laz 509) or in 10% IL-2 in the presence or absence of each 
purified anti-T lymphocyte antibody (20 #g/ml). (B) Cells of clone AC3 were preincubated with anti- 
T3 antibodies for 18 h at 37°C, subsequently washed to remove free monoclonal antibody and then 
3 x  104 cells cultured  with 5 x  104 irradiated  Laz 509 or 10% IL-2 as above. Unmodulated  AC3 
cells were preincubated  with media. Results are expressed as cpm + SD. BENSUSSAN  ET  AL.  569 
FIGURE 4.  SDS-PAGE of anti-T3 immunoprecipitates from t*5I-labeled AC3 clone. T-x-100 
lysates from 1251-1actoperoxidase catalyzed surface labeling of AC3 were immunoprecipitated 
with anti-T3 monoclonal antibody as described in Materials and Methods. A, control (anti- 
T6), reduced; B, anti-T3, reduced; C, control, nonreduced; D, anti-T3, nonreduced. 
four bands  on  SDS-PAGE  under  reducing  conditions  from  AC3  (lane B):  the 
major protein  has a  molecular  weight of 20 kD with three additional  bands at 
25, 43, and  52  kD.  More importantly,  the two higher  molecular weight bands 
correspond to the a  and fl subunits of the Ti structure  that have been defined 
on other clones. Further support for this notion comes from the fact that under 
nonreducing  conditions,  the  52- and  43-kD  upper bands  detected by anti-T3c 
appear  as  a  90-kD  structure  (lane  D).  Note  that  the  20-  and  25-kD  subunits 
within the anti-T3  precipitate are similar under both reduced and nonreduced 
conditions.  Taken  together with  the functional  data,  these results suggest that 
the T3 complex on alloreactive and autoreactive clones is analogous. 
Discussion 
In the present study, peripheral  blood mononuclear cells were stimulated by 
an  autoiogous  ragweed  antigen-specific,  MHC-restricted  T4+  inducer  clone 
termed  RW 17C and the resulting  T  cells clones were propagated in long-term 
in vitro culture (_>6 months).  13 T4+ clones (ACI-13) were generated and found 
to be reactive  with autologous class  II  but not class I  MHC gene products,  as 
defined by monoclonal  antibody blocking studies and  the  unique  specificity of 
AC 1-13 for autologous but not allogeneic B lymphoblastoid line cells. Moreover, 570  T4+  AUTOREACTIVE CLONES 
the ability of different autologous peripheral blood cell types to serve as stimu- 
lators for AC 1-13  proliferation appeared to correlate with their surface density 
of Ia molecules. Thus, Ia- autologous T  cells were not stimulatory, whereas Ia+ 
autologous  B  cells,  macrophages,  and  B  iymphoblastoid  cells,  in  that  order, 
induced increasing amounts of proliferation. 
These same AC (i.e. AC3) induced autologous B cells to produce large amounts 
of immunoglobulin in the absence of exogenous antigen.  In contrast,  the im- 
munizing clone RW17C  induced autologous B  cell  Ig production  only in  the 
presence  of the  exogenous  soluble  antigen  RWAGE.  However,  both  sets  of 
clones could trigger allogeneic B cells to produce Ig as long as autologous class 
II  bearing cells (i.e.  macrophages and in the case of RW17C,  RWAGE) were 
present. The latter results imply that initiation of helper function from either 
type of clonal population is MHC restricted, whereas production of IgG can be 
induced from both autologous as well as ailogeneic B cells. However, whether 
specific IgG production is MHC restricted is still  to be resolved. Furthermore, 
the enhancement of Ig production from the combination of AC3 and RW 17C 
cloned cells suggests that autociones such as AC3  subserve a  normal amplifier 
function. The finding that AC that appear after immunization recognize a "self" 
Ia  molecule and  are involved in  amplifier function implies that  they may be 
components of a critical immunoregulatory inducer circuit. 
It is particularly interesting that the AC clones resulted from stimulation of 
PBMC  with  irradiated  RW17C,  yet were  themselves only  minimally able  to 
proliferate to RW17C directly. These results suggested that RW17C served to 
trigger a  second population  to stimulate ACI-13  proliferation. Given that the 
AC clones are class  II specific, it is possible that the latter was either a B cell or 
a  macrophage. The inductive capacity of AC3 on B cell Ig production further 
supports this view. 
Prior studies at the heterogeneous population level have provided support for 
the notion that amplifier populations for B and T  cell responses exist in both 
man and mouse (30-32). For example, in the human system, T4+ amplifier cells 
appear  to  preferentially express  Ia  antigen  early in  the course of activation. 
Thus, when soluble antigen-stimulated T cells were separated after 6 d of culture 
into T4+Ia+ and T4+Ia- populations, it was found that the majority of prolif- 
eration was contained within the Ia+ fraction and that most of this was nonspe- 
cific.  More  importantly,  each  of the  T4+  subsets  alone  induced  B  cell  Ig 
production, but only together provided maximal induction of helper function 
(30). Although the present set of autoreactive T  cells was generated from culture 
with RW 17C, it is also clear that T  cells reactive with self-MHC antigens can be 
generated by other means.  In  fact,  when one immunizes with  antigen-pulsed 
macrophages,  one  elicits  clones specific for antigen and  self-MHC  as  well  as 
autoreactive clones directed at autologous  MHC  molecules (data not  shown). 
Note that the polymorphic class II specificity of these and other clones and their 
growth in human serum argues against the possibility that such cells are directed 
at xenogeneic protein determinants, as suggested by others to explain apparent 
autoreactivity (33). 
The present findings suggest that positive induction of immune responses in 
man  may occur at  either of two  levels  (Fig.  5).  One  level  is  soluble  antigen BENSUSSAN  ET  AL. 
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FIGURE 5.  Model of soluble antigen-dependent and independent clonal T  cell interaction. 
Soluble (foreign) antigen (A)  in the  context  of autologous class  II  MHC  (~t~-)  leads to 
activation (-..) of Ag specific T4+ inducer T  lymphocytes via their specific  T3-Ti molecular 
complex which serves as receptor for both Ag and MHC. Subsequently, monocytes and/or B 
lymphocytes are activated (---~) which results in triggering of autoreactive self-class II MHC 
specific  (--,) clones as a result of their own unique T3-Ti molecular complex. These soluble 
antigen independent (autoreactive) clones further activate B cells (--,) and amplify the function 
of the soluble antigen dependent inducer cell. 
dependent and  MHC restricted as exemplified by RW17C,  and the second is 
soluble antigen-independent and requires only autologous class II recognition. 
Such an  antigen-"independent"  level  of immunoregulation is  initiated  by an 
internal set of signals (i.e.  autologous MHC) and in conjunction with antigen- 
"dependent" inducer cells may serve to markedly amplify the immune response. 
This could be particularly important after antigen has been degraded and is no 
longer able to provide continued stimulation of the antigen-"dependent" level of 
immune induction. 
The observation that RW 17C induced little AC 1-13 proliferation despite the 
fact that it expressed autologous Ia molecules is of considerable interest. While 
it is conceivable that the level of Ia expression on RW 17C is simply too low to 
stimulate these clones to proliferate, one cannot rule out the possibility that a 
specific MHC class II gene product required for T cell stimulation is absent from 
the surface of RW17C.  In this regard, it is well known that the class  II MHC 
gene locus is complex and consists of at least three separate regions encoding for 
DR, DC, and SB (34). Molecular approaches to the problem including Northern 
blot analysis of T  cell clone mRNA with cDNA probes to each of these regions 
will be important to study. 
There is considerable evidence that endogenous synthesis and expression of 
Ia molecules occur as a consequence of T cell activation (35-37). Therefore, the 
possible  failure of T  cell "Ia"  to  induce secondary responses, as suggested by 
others (38),  may be an important mechanism to limit further immune respon- 
siveness by other T  cells. While lack of stimulation by T  cell Ia may have some 
direct regulatory effect, additional mechanisms yet to be defined and probably 
involving T8  suppressor  cells  generated during  the  autologous  response  are 
likely more important to control amplification mediated by clones such as AC 1- 
13.  Subsequent analysis of the T8+ populations generated during stimulation 
will be critical. 
A model of human T  cell antigen recognition has been proposed on the basis 
of functional and biochemical analysis of surface components on T  lymphocytes 572  T4+  AITTOREACTIVE  CLONES 
with specificities directed at allo class  I or class  II MHC gene products or viral 
gene products in the context of autologous MHC molecules. It was hypothesized 
that the T3-Ti  molecular complex viewed polymorphic self-MHC plus antigen 
X  (or polymorphic alloantigen alone),  whereas T4  and T8  served as ancillary 
associative recognition structures for monomorphic regions of class II or class I 
molecules, respectively (39). Several independent lines of evidence suggest that 
T3-Ti  is  the T  cell receptor: (a)  both  0~ and ~  subunits of Ti  molecules from 
clones of differing specificities (but derived from the same donor) contain clonally 
unique peptides on two-dimensional peptide map analysis (40) and (b) anti-T3 or 
the appropriate anti-Ti antibody covalently cross-linked to Sepharose is, by itself, 
capable of triggering clonai proliferation and lymphokine production analogous 
to the combination of antigen and MHC restricting elements (41). 
In contrast, T4 and T8 do not appear to be specific antigen receptor molecules. 
Sepharose-bound anti-T4 and anti-T8 antibodies do not trigger clonal prolifer- 
ation and there is no biochemical evidence to suggest that that structures that 
they define are  polymorphic at  the  peptide  level.  Nevertheless,  T4  and  T8 
appear to be extremely important in facilitating cell-cell interactions by, presum- 
ably, providing additional affinity for ligand binding in conjunction with T3-Ti 
molecular complex. That this is the case is clearly evident from the observation 
that soluble anti-T4 and anti-T8  antibodies are capable of blocking killing by 
CTL directed at class II and class I MHC gene products, respectively on target 
cells. (1, 2, 4, 43). 
The present study supports the view that autoreactive clones like AC3 recog- 
nize a polymorphic region of a class II molecules since it proliferated to autolo- 
gous but not allogeneic Ia. The observation that anti-T3 modulation abrogates 
this proliferative response implies that the recognition ofautologous polymorphic 
regions of MHC gene occurs via T3-Ti and that T4 is not the singular recognition 
site for class  II  MHC gene products.  Moreover, the ability of purified anti-T4 
antibody to block the AC3 proliferation induced by autologous class II molecules 
further supports the notion that T4 may facilitate binding of class II molecules 
to T  cells, particularly if T3-Ti binding to auto-MHC is low affinity. 
It is of interest that earlier studies with class  II allospecific CTL  in  general 
demonstrated profound blocking of cytotoxicity but only partial, if any, blocking 
of alloantigen-induced proliferation by anti-T4  (9).  Given the  likelihood that 
there is a more stringent requirement for cell-cell contact in the former response, 
this differential effect is not surprising.  The rather complete blocking by anti- 
T4 of autoreactive AC3 proliferation to autologous MHC class II gene products 
contrasts with the minimal effects of anti-T4 on alloreactive clonal proliferation 
reported previously (9).  It is possible that this difference may be related to the 
lower  affinity of self-MHC-specific  T3-Ti  complexes  in  comparison  to  allo- 
MHC-specific T3-Ti complexes. 
While we have yet to prepare a monocional antibody to the c[onotype of one 
or  another  AC,  the  biochemical  evidence  to  date  indicates  that  the  T3-Ti 
molecular complex of AC3 is strikingly similar to T3-Ti molecular complexes of 
alloreactive CTL in terms of their component subunits (29). Thus, anti-T3 could 
precipitate in addition to 20/25-kD structures, 43-kD, and 52-kD components 
analogous to those found on allogeneic clones. Moreover, under nonreducing BENSUSSAN ET AL.  573 
conditions, the 43- and 52-kD components appeared as a 90-kD band consistent 
with  the  notion  that  the  clonotypic structure  on  AC3  was  a  disulfide-linked 
heterodimer,  as  previously  found  on  "conventional"  alloreactive  and  MHC- 
restricted/antigen-specific T  cell clones (9).  These findings imply that T3-Ti is 
essential for all forms of antigen recognition, even those restricted to autologous 
MHC gene products.  Presumably some T3-Ti  complexes view antigen X  and 
self-MHC (i.e. T3-Ti from RW17C), others view self-MHC alone (i.e. AC3) and 
yet others view antigen X alone. Perhaps an example of the "antigen X alone" 
clone is the recently described natural killer (NK)-like T  cell clone, which clearly 
had a broad but definite specificity unrelated to MHC antigens (44). 
Although we have defined no clones in the present study with unique specificity 
for the stimulating clone RW 17C, others have demonstrated such specific clone 
anti-clone responses (16). Thus, it would seem possible that some T3-Ti molec- 
ular complexes could be directed at autologous T3-Ti structures on clones of 
differing specificities. The latter might account for regulation at the clonal level. 
The autoreactive nature of ACI-13,  their specificity for class  II MHC gene 
products,  T4+  subset derivation,  and lack of cytotoxic effector functions are 
characteristics that  have  been  described  for  cells  proliferating in  autologous 
mixed lymphocyte reaction (AMLR) in  human peripheral blood  (11-15,  17). 
Presumably, ACI-I 3 cells represent the clonal counterpart of the AMLR respon- 
sive cell in peripheral blood.  These studies suggest that such cells subserve an 
amplifier function in T  cell regulation of the normal immune response. Given 
the existence of such autoreactive cells in healthy donors and the ease with which 
they can be elicited, their existence argues against the concept of clonal deletion 
in  self tolerance.  Understanding  of the  regulation  of the  AC  response  now 
becomes important as it may provide further insights into both physiologic and 
pathologic immune functions, including autoimmunity. 
Summary 
Autoreactive T  lymphocytes were generated by culturing human peripheral 
blood mononuclear cells with an antigen-specific major histocompatibility com- 
plex  (MHC)-restricted autologous inducer T  cell,  termed RW17C  and  subse- 
quently cloned in soft agar. The majority of such clones (AC 1-13) expressed the 
T3+T4+T8-T  1 1  +Ia+ phenotype and were directed at autologous class II MHC 
gene products  found on  B  cells,  macrophages, and  B  lymphoblastoid cells as 
judged by their proliferative response to  the  latter.  For this  recognition, the 
clones employed a  T3-Ti molecular complex and a T4 structure analogous to 
those found on allospecific T  cells. Perhaps more importantly, it was observed 
that the same ACI-13  autoreactive clones (AC) induced autologous B cells to 
produce high levels of immunoglobulin in the absence of exogenous antigen and 
could synergize with the RW17C clone to effect maximal B cell Ig production. 
These results support the notion that such autoreactive cells can function in a 
physiologic amplifier role by facilitating induction via an internal set of signals 
(i.e. autologous MHC). 
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